GE HealthCare Technologies Inc. (NASDAQ:GEHC) Given Average Recommendation of “Hold” by Brokerages

Posted by on Aug 6th, 2026

Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC – Get Free Report) have been given a consensus recommendation of “Hold” by the twenty-one analysts that are currently covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating and ten have issued a buy rating on the company. The average 1-year target price among analysts that have updated their coverage on the stock in the last year is $77.7273.

A number of analysts have recently commented on GEHC shares. JPMorgan Chase & Co. lowered their price target on GE HealthCare Technologies from $80.00 to $65.00 and set a “neutral” rating for the company in a research note on Thursday, April 30th. Stifel Nicolaus set a $80.00 price objective on shares of GE HealthCare Technologies in a research note on Wednesday, April 29th. BTIG Research boosted their price objective on shares of GE HealthCare Technologies from $75.00 to $79.00 and gave the company a “buy” rating in a report on Wednesday, July 29th. Jefferies Financial Group lowered their target price on shares of GE HealthCare Technologies from $105.00 to $90.00 in a research note on Thursday, April 30th. Finally, Weiss Ratings lowered shares of GE HealthCare Technologies from a “hold (c)” rating to a “hold (c-)” rating in a report on Friday, May 15th.

Check Out Our Latest Report on GEHC

Insider Buying and Selling

In other GE HealthCare Technologies news, Director Kevin Lobo acquired 10,000 shares of the company’s stock in a transaction that occurred on Friday, May 22nd. The shares were acquired at an average price of $64.18 per share, with a total value of $641,800.00. Following the purchase, the director owned 14,363 shares of the company’s stock, valued at $921,817.34. This represents a 229.20% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Rodney F. Hochman bought 1,618 shares of the firm’s stock in a transaction on Tuesday, May 12th. The stock was acquired at an average cost of $62.03 per share, with a total value of $100,364.54. Following the completion of the purchase, the director owned 1,618 shares of the company’s stock, valued at approximately $100,364.54. This trade represents a ∞ increase in their position. The SEC filing for this purchase provides additional information. In the last quarter, insiders have acquired 12,618 shares of company stock valued at $805,175. 0.36% of the stock is owned by company insiders.

Hedge Funds Weigh In On GE HealthCare Technologies

Several institutional investors and hedge funds have recently modified their holdings of the business. Empowered Funds LLC lifted its stake in GE HealthCare Technologies by 6.1% in the first quarter. Empowered Funds LLC now owns 28,848 shares of the company’s stock valued at $2,328,000 after buying an additional 1,665 shares in the last quarter. Acadian Asset Management LLC bought a new stake in GE HealthCare Technologies in the 1st quarter valued at $259,000. Cresset Asset Management LLC boosted its stake in GE HealthCare Technologies by 12.5% in the 2nd quarter. Cresset Asset Management LLC now owns 7,802 shares of the company’s stock worth $578,000 after purchasing an additional 865 shares during the period. Jump Financial LLC boosted its stake in GE HealthCare Technologies by 317.6% in the 2nd quarter. Jump Financial LLC now owns 28,132 shares of the company’s stock worth $2,084,000 after purchasing an additional 21,396 shares during the period. Finally, Gamco Investors INC. ET AL increased its holdings in GE HealthCare Technologies by 8.6% during the 2nd quarter. Gamco Investors INC. ET AL now owns 4,041 shares of the company’s stock worth $299,000 after purchasing an additional 320 shares in the last quarter. 82.06% of the stock is currently owned by institutional investors and hedge funds.

GE HealthCare Technologies Stock Down 0.0%

Shares of GE HealthCare Technologies stock opened at $70.24 on Friday. The company has a quick ratio of 0.97, a current ratio of 1.26 and a debt-to-equity ratio of 0.92. GE HealthCare Technologies has a 12 month low of $58.75 and a 12 month high of $89.77. The business has a fifty day simple moving average of $64.38 and a 200 day simple moving average of $70.14. The stock has a market cap of $31.73 billion, a PE ratio of 16.11, a price-to-earnings-growth ratio of 2.03 and a beta of 0.69.

GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last released its earnings results on Wednesday, July 29th. The company reported $1.13 earnings per share for the quarter, beating the consensus estimate of $1.04 by $0.09. GE HealthCare Technologies had a return on equity of 20.12% and a net margin of 9.33%.The firm had revenue of $5.29 billion for the quarter, compared to analyst estimates of $5.26 billion. During the same quarter in the prior year, the firm posted $1.06 earnings per share. The company’s quarterly revenue was up 5.8% on a year-over-year basis. Research analysts predict that GE HealthCare Technologies will post 4.93 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 14th. Investors of record on Friday, July 24th will be given a $0.035 dividend. The ex-dividend date is Friday, July 24th. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio is currently 3.21%.

About GE HealthCare Technologies

(Get Free Report)

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.

Featured Stories

Analyst Recommendations for GE HealthCare Technologies (NASDAQ:GEHC)

Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.